Utah Medical Products, Inc. $UTMD Shares Bought by Hotchkis & Wiley Capital Management LLC

Key Points

• Hotchkis & Wiley Capital Management LLC increased its stake in Utah Medical Products, Inc. by 35.2%, owning 101,640 shares valued at approximately $5.7 million as of its latest SEC filing.
• Various hedge funds have also significantly increased their positions in Utah Medical Products, with Tower Research Capital boosting its stake by 172.6%, reflecting a growing institutional interest in the company.
• Utah Medical Products recently announced a quarterly dividend of $0.305 per share, with an annualized dividend yield of 2.0%, indicative of the company's strong profitability with a net margin of 32.34%.

Hotchkis & Wiley Capital Management LLC raised its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 35.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 101,640 shares of the medical instruments supplier's stock after buying an additional 26,460 shares during the period. Hotchkis & Wiley Capital Management LLC owned about 3.10% of Utah Medical Products worth $5,696,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Everett Harris & Co. CA raised its stake in Utah Medical Products by 327.7% in the first quarter. Everett Harris & Co. CA now owns 17,116 shares of the medical instruments supplier's stock valued at $959,000 after buying an additional 13,114 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Utah Medical Products by 6.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 186,700 shares of the medical instruments supplier's stock valued at $11,476,000 after buying an additional 11,196 shares in the last quarter. Minerva Advisors LLC raised its stake in Utah Medical Products by 10.9% in the first quarter. Minerva Advisors LLC now owns 86,902 shares of the medical instruments supplier's stock valued at $4,870,000 after buying an additional 8,513 shares in the last quarter. Nuveen LLC acquired a new stake in Utah Medical Products in the first quarter valued at $449,000. Finally, Marshall Wace LLP raised its stake in Utah Medical Products by 145.3% in the fourth quarter. Marshall Wace LLP now owns 11,850 shares of the medical instruments supplier's stock valued at $728,000 after buying an additional 7,019 shares in the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Stock Up 1.5%

Utah Medical Products stock traded up $0.94 during midday trading on Thursday, reaching $62.06. The company's stock had a trading volume of 7,711 shares, compared to its average volume of 14,519. Utah Medical Products, Inc. has a fifty-two week low of $51.26 and a fifty-two week high of $68.99. The company has a market cap of $198.96 million, a P/E ratio of 16.59 and a beta of 0.31. The business has a 50-day simple moving average of $57.20 and a 200-day simple moving average of $56.32.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. Utah Medical Products had a return on equity of 10.55% and a net margin of 32.34%.The business had revenue of $9.95 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be given a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.0%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's payout ratio is 32.62%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.